Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Philip L. Johnson currently holds 56,431 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Philip L. Johnson has been a net buyer of JAZZ stock. They have purchased $1.4M and sold $0 worth of shares.
Philip L. Johnson's most recent insider trade was on Jun 30, 2026, when they sold 3,343 shares at $237.72 per share.
Philip L. Johnson serves as Executive at Jazz Pharmaceuticals plc (JAZZ). They have executed 4 insider transactions totaling $1.4M over their tenure at the company.
Philip L. Johnson holds the position of Executive at Jazz Pharmaceuticals plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Philip L. Johnson has shown a buying trading pattern, with $1.4M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Philip L. Johnson was on Mar 1, 2024, when they purchased $1.4M worth of JAZZ shares. This transaction involved 12,000 shares at $119.65 per share.
Philip L. Johnson currently owns 56,431 shares of Jazz Pharmaceuticals plc (JAZZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Philip L. Johnson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Philip L. Johnson has 4 Form 4 filings on record as an insider at Jazz Pharmaceuticals plc.
Set alerts for Philip L. Johnson and 40,000+ other insiders.